Maria Siemionow
Oprichter bij Dystrogen Therapeutics Corp.
Profiel
Maria Siemionow is associated with two companies, Tolera Therapeutics, Inc. and Dystrogen Therapeutics Corp.
She was the Chief Science Technology Officer at Tolera Therapeutics, Inc. and the Chief Scientific Officer at Dystrogen Therapeutics Corp.
Dr. Siemionow founded Tolera Therapeutics, Inc. in 2007 and founded Dystrogen Therapeutics Corp.
in 2017.
Actieve functies van Maria Siemionow
| Bedrijven | Functie | Begin |
|---|---|---|
Dystrogen Therapeutics Corp.
 Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Oprichter | 01-01-2017 |
Eerdere bekende functies van Maria Siemionow
| Bedrijven | Functie | Einde |
|---|---|---|
Tolera Therapeutics, Inc.
 Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tolera Therapeutics, Inc. develops novel therapies and technologies for immune modulation. Its products include anti-aßTCR antibody an immune induction therapy in solid organ transplantation and graft versus host disease. The company was founded by Jake Orville, Maria Siemionow, James J. Herrmann and John J. Puisis in 2007 and is headquartered in Ann Arbor, MI. | Commercial Services |
Dystrogen Therapeutics Corp.
Dystrogen Therapeutics Corp. Packaged SoftwareTechnology Services Dystrogen Therapeutics Corp. develops platform for therapies of rare genetic diseases. The company was founded by Kris Siemionow, Maria Siemionow, and Paul Lewicki in 2017 and is headquartered in Chicago, IL. | Technology Services |
